EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Adequate Dose of Levothyroxine for Thyroid-Stimulating Hormone Suppression after Total Thyroidectomy in Patients with Differentiated Thyroid Cancer

Hyun Jin Ryu, Min Sun Choi, Hyunju Park, Tae Hyuk Kim, Jae Hoon Chung, So Young Park, Sun Wook Kim

Endocrinology and Metabolism · 2024

DOI: 10.3803/enm.2023.1896 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology and Metabolism, 2024. Verfasst von Hyun Jin Ryu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine,…. Hauptthemen laut MEDLINE: Thyroidectomy, Thyroxine, Thyrotropin, Thyroid Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The adequate dose of levothyroxine (LT4) for patients who have undergone total thyroidectomy (TT) for differentiated thyroid cancer (DTC) is uncertain. We evaluated the LT4 dose required to achieve mild thyroid-stimulating hormone (TSH) suppression in DTC patients after TT.

Methods

The electronic medical records of patients who underwent TT for DTC and received mild TSH suppression therapy were reviewed. Linear regression analysis was performed to evaluate the association between LT4 dose (μg/kg) and an ordinal group divided by body mass index (BMI). We also evaluated the trend in LT4 doses among groups divided by BMI and age.

Results

In total, 123 patients achieved mild TSH suppression (0.1 to 0.5 mIU/L). The BMI variable was divided into three categories:

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThyroidectomyThyroxineThyrotropinThyroid NeoplasmsBody Mass IndexHumansFemaleMaleMiddle AgedAdultRetrospective StudiesAged

Stichwörter der Autor:innen

Body mass indexLevothyroxineThyroid neoplasmsThyroid-stimulating hormone suppression

Substanzen

ThyroxineThyrotropin

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Medicine, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Korea.
  • Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
  • Division of Endocrinology and Metabolism, Department of Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.

Zitieren

APA

Ryu, H. J., Choi, M. S., Park, H., Kim, T. H., Chung, J. H., Park, S. Y., & Kim, S. W. (2024). Adequate Dose of Levothyroxine for Thyroid-Stimulating Hormone Suppression after Total Thyroidectomy in Patients with Differentiated Thyroid Cancer. Endocrinology and Metabolism. https://doi.org/10.3803/enm.2023.1896

Vancouver

Ryu HJ, Choi MS, Park H, Kim TH, Chung JH, Park SY, et al. Adequate Dose of Levothyroxine for Thyroid-Stimulating Hormone Suppression after Total Thyroidectomy in Patients with Differentiated Thyroid Cancer. Endocrinology and Metabolism. 2024. doi:10.3803/enm.2023.1896

BibTeX
@article{Ryu2024,
  author = {Ryu, Hyun Jin and Choi, Min Sun and Park, Hyunju and Kim, Tae Hyuk and Chung, Jae Hoon and Park, So Young and Kim, Sun Wook},
  title = {Adequate Dose of Levothyroxine for Thyroid-Stimulating Hormone Suppression after Total Thyroidectomy in Patients with Differentiated Thyroid Cancer},
  journal = {Endocrinology and Metabolism},
  year = {2024},
  doi = {10.3803/enm.2023.1896}
}
Kostenlos starten →